Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
BMC Genomics
|
April 16, 2021
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines
Yuanyuan Li, David M Umbach, Juno M Krahn, et al.
Cancer Research
|
August 23, 2013
FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function
Igor Shats, Michael L Gatza, Beiyu Liu, et al.
Plos Computational Biology
|
December 3, 2019
CDSeq: A novel complete deconvolution method for dissecting heterogeneous samples using gene expression data
Kai Kang, Qian Meng, Igor Shats, et al.
Cancer Research
|
December 21, 2010
Using a stem cell-based signature to guide therapeutic selection in cancer
Igor Shats, Michael L Gatza, Jeffrey T Chang, et al.
Plos One
|
June 15, 2019
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
Yuanyuan Li, Melissa Li, Igor Shats, et al.
Cell Death and Differentiation
|
February 18, 2017
Expression level is a key determinant of E2F1-mediated cell fate
Igor Shats, Michael Deng, Adam Davidovich, et al.
Molecular Systems Biology
|
May 27, 2006
The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation
Yuval Tabach, Michael Milyavsky, Igor Shats, et al.
The Journal of Biological Chemistry
|
September 17, 2004
p53-dependent down-regulation of telomerase is mediated by p21waf1
Igor Shats, Michael Milyavsky, Xiaohu Tang, et al.
Cancer Research
|
November 13, 2003
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype
Michael Milyavsky, Igor Shats, Neta Erez, et al.
Plos One
|
November 13, 2008
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner
Alina Molchadsky, Igor Shats, Naomi Goldfinger, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
BMC Genomics
|
April 16, 2021
Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines
Yuanyuan Li, David M Umbach, Juno M Krahn, et al.
Cancer Research
|
August 23, 2013
FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function
Igor Shats, Michael L Gatza, Beiyu Liu, et al.
Plos Computational Biology
|
December 3, 2019
CDSeq: A novel complete deconvolution method for dissecting heterogeneous samples using gene expression data
Kai Kang, Qian Meng, Igor Shats, et al.
Cancer Research
|
December 21, 2010
Using a stem cell-based signature to guide therapeutic selection in cancer
Igor Shats, Michael L Gatza, Jeffrey T Chang, et al.
Plos One
|
June 15, 2019
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
Yuanyuan Li, Melissa Li, Igor Shats, et al.
Cell Death and Differentiation
|
February 18, 2017
Expression level is a key determinant of E2F1-mediated cell fate
Igor Shats, Michael Deng, Adam Davidovich, et al.
Molecular Systems Biology
|
May 27, 2006
The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation
Yuval Tabach, Michael Milyavsky, Igor Shats, et al.
The Journal of Biological Chemistry
|
September 17, 2004
p53-dependent down-regulation of telomerase is mediated by p21waf1
Igor Shats, Michael Milyavsky, Xiaohu Tang, et al.
Cancer Research
|
November 13, 2003
Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype
Michael Milyavsky, Igor Shats, Neta Erez, et al.
Plos One
|
November 13, 2008
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner
Alina Molchadsky, Igor Shats, Naomi Goldfinger, et al.
Page
of 3